These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


265 related items for PubMed ID: 24414419

  • 1. Stratifying fascin and cortactin function in invadopodium formation using inhibitory nanobodies and targeted subcellular delocalization.
    Van Audenhove I, Boucherie C, Pieters L, Zwaenepoel O, Vanloo B, Martens E, Verbrugge C, Hassanzadeh-Ghassabeh G, Vandekerckhove J, Cornelissen M, De Ganck A, Gettemans J.
    FASEB J; 2014 Apr; 28(4):1805-18. PubMed ID: 24414419
    [Abstract] [Full Text] [Related]

  • 2. Nanobodies targeting cortactin proline rich, helical and actin binding regions downregulate invadopodium formation and matrix degradation in SCC-61 cancer cells.
    Bertier L, Hebbrecht T, Mettepenningen E, De Wit N, Zwaenepoel O, Verhelle A, Gettemans J.
    Biomed Pharmacother; 2018 Jun; 102():230-241. PubMed ID: 29567535
    [Abstract] [Full Text] [Related]

  • 3. Fascin actin bundling controls podosome turnover and disassembly while cortactin is involved in podosome assembly by its SH3 domain in THP-1 macrophages and dendritic cells.
    Van Audenhove I, Debeuf N, Boucherie C, Gettemans J.
    Biochim Biophys Acta; 2015 May; 1853(5):940-52. PubMed ID: 25601713
    [Abstract] [Full Text] [Related]

  • 4. Inhibitory cortactin nanobodies delineate the role of NTA- and SH3-domain-specific functions during invadopodium formation and cancer cell invasion.
    Bertier L, Boucherie C, Zwaenepoel O, Vanloo B, Van Troys M, Van Audenhove I, Gettemans J.
    FASEB J; 2017 Jun; 31(6):2460-2476. PubMed ID: 28235780
    [Abstract] [Full Text] [Related]

  • 5. Cortactin and fascin-1 regulate extracellular vesicle release by controlling endosomal trafficking or invadopodia formation and function.
    Beghein E, Devriese D, Van Hoey E, Gettemans J.
    Sci Rep; 2018 Oct 23; 8(1):15606. PubMed ID: 30353022
    [Abstract] [Full Text] [Related]

  • 6. Dissecting the functional domain requirements of cortactin in invadopodia formation.
    Webb BA, Jia L, Eves R, Mak AS.
    Eur J Cell Biol; 2007 Apr 23; 86(4):189-206. PubMed ID: 17343955
    [Abstract] [Full Text] [Related]

  • 7. Dynamic interactions of cortactin and membrane type 1 matrix metalloproteinase at invadopodia: defining the stages of invadopodia formation and function.
    Artym VV, Zhang Y, Seillier-Moiseiwitsch F, Yamada KM, Mueller SC.
    Cancer Res; 2006 Mar 15; 66(6):3034-43. PubMed ID: 16540652
    [Abstract] [Full Text] [Related]

  • 8. An invasion-related complex of cortactin, paxillin and PKCmu associates with invadopodia at sites of extracellular matrix degradation.
    Bowden ET, Barth M, Thomas D, Glazer RI, Mueller SC.
    Oncogene; 1999 Aug 05; 18(31):4440-9. PubMed ID: 10442635
    [Abstract] [Full Text] [Related]

  • 9. VCA nanobodies target N-WASp to reduce invadopodium formation and functioning.
    Hebbrecht T, Van Audenhove I, Zwaenepoel O, Verhelle A, Gettemans J.
    PLoS One; 2017 Aug 05; 12(9):e0185076. PubMed ID: 28938008
    [Abstract] [Full Text] [Related]

  • 10. The cortactin-binding domain of WIP is essential for podosome formation and extracellular matrix degradation by murine dendritic cells.
    Bañón-Rodríguez I, Monypenny J, Ragazzini C, Franco A, Calle Y, Jones GE, Antón IM.
    Eur J Cell Biol; 2011 Aug 05; 90(2-3):213-23. PubMed ID: 20952093
    [Abstract] [Full Text] [Related]

  • 11. Phosphorylated cortactin recruits Vav2 guanine nucleotide exchange factor to activate Rac3 and promote invadopodial function in invasive breast cancer cells.
    Rosenberg BJ, Gil-Henn H, Mader CC, Halo T, Yin T, Condeelis J, Machida K, Wu YI, Koleske AJ.
    Mol Biol Cell; 2017 May 15; 28(10):1347-1360. PubMed ID: 28356423
    [Abstract] [Full Text] [Related]

  • 12. Cortactin promotes cell motility by enhancing lamellipodial persistence.
    Bryce NS, Clark ES, Leysath JL, Currie JD, Webb DJ, Weaver AM.
    Curr Biol; 2005 Jul 26; 15(14):1276-85. PubMed ID: 16051170
    [Abstract] [Full Text] [Related]

  • 13. Molecular mechanisms of invadopodium formation: the role of the N-WASP-Arp2/3 complex pathway and cofilin.
    Yamaguchi H, Lorenz M, Kempiak S, Sarmiento C, Coniglio S, Symons M, Segall J, Eddy R, Miki H, Takenawa T, Condeelis J.
    J Cell Biol; 2005 Jan 31; 168(3):441-52. PubMed ID: 15684033
    [Abstract] [Full Text] [Related]

  • 14. Cortactin interacts with WIP in regulating Arp2/3 activation and membrane protrusion.
    Kinley AW, Weed SA, Weaver AM, Karginov AV, Bissonette E, Cooper JA, Parsons JT.
    Curr Biol; 2003 Mar 04; 13(5):384-93. PubMed ID: 12620186
    [Abstract] [Full Text] [Related]

  • 15. WIP and WICH/WIRE co-ordinately control invadopodium formation and maturation in human breast cancer cell invasion.
    García E, Ragazzini C, Yu X, Cuesta-García E, Bernardino de la Serna J, Zech T, Sarrió D, Machesky LM, Antón IM.
    Sci Rep; 2016 Mar 24; 6():23590. PubMed ID: 27009365
    [Abstract] [Full Text] [Related]

  • 16. Fascin, an actin-bundling protein, modulates colonic epithelial cell invasiveness and differentiation in vitro.
    Jawhari AU, Buda A, Jenkins M, Shehzad K, Sarraf C, Noda M, Farthing MJ, Pignatelli M, Adams JC.
    Am J Pathol; 2003 Jan 24; 162(1):69-80. PubMed ID: 12507891
    [Abstract] [Full Text] [Related]

  • 17. Invadopodia-associated proteins blockade as a novel mechanism for 6-shogaol and pterostilbene to reduce breast cancer cell motility and invasion.
    Hong BH, Wu CH, Yeh CT, Yen GC.
    Mol Nutr Food Res; 2013 May 24; 57(5):886-95. PubMed ID: 23417847
    [Abstract] [Full Text] [Related]

  • 18. Snail1 induced in breast cancer cells in 3D collagen I gel environment suppresses cortactin and impairs effective invadopodia formation.
    Lee MS, Kim S, Kim BG, Won C, Nam SH, Kang S, Kim HJ, Kang M, Ryu J, Song HE, Lee D, Ye SK, Jeon NL, Kim TY, Cho NH, Lee JW.
    Biochim Biophys Acta; 2014 Sep 24; 1843(9):2037-54. PubMed ID: 24861866
    [Abstract] [Full Text] [Related]

  • 19. Co-localization of cortactin and phosphotyrosine identifies active invadopodia in human breast cancer cells.
    Bowden ET, Onikoyi E, Slack R, Myoui A, Yoneda T, Yamada KM, Mueller SC.
    Exp Cell Res; 2006 May 01; 312(8):1240-53. PubMed ID: 16442522
    [Abstract] [Full Text] [Related]

  • 20. Cortactin is an essential regulator of matrix metalloproteinase secretion and extracellular matrix degradation in invadopodia.
    Clark ES, Whigham AS, Yarbrough WG, Weaver AM.
    Cancer Res; 2007 May 01; 67(9):4227-35. PubMed ID: 17483334
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.